drugset / Trial / NCT00364689

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

NCT00364689

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of three different treatments for hepatic encephalopathy.

Timeline

Start
2006-08
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactulose Other / unclassified
Subject Rifaximin Other / unclassified